Trial intelligence / Profile preview

PSI vs BIS Guidance for Remimazolam-Based General Anesthesia in Laparoscopic Total Hysterectomy

ChiCTR2600129872Phase 4Not yet recruiting

Sponsor
Jiangsu Provincial People's Hospital
Start
Aug 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam in Not applicable (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Dosage of remimazolam per unit time. Planned start Aug 2026; status: not yet recruiting.

02

Drugs

remimazolam
03

Conditions

Not applicable

Beyond the preview

Go deeper on ChiCTR2600129872.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2600129872.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call